These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 19731867)

  • 1. [Treatment of hypertension in metabolic syndrome].
    Widimský J
    Vnitr Lek; 2009; 55(7-8):631-5. PubMed ID: 19731867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolic syndrome in hypertension: European society of hypertension position statement.
    Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G;
    J Hypertens; 2008 Oct; 26(10):1891-900. PubMed ID: 18806611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome: treatment of hypertensive patients.
    Israili ZH; Lyoussi B; Hernández-Hernández R; Velasco M
    Am J Ther; 2007; 14(4):386-402. PubMed ID: 17667215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
    JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of β-blockers in patients with metabolic syndrome and hypertension].
    Dézsi CA
    Orv Hetil; 2015 Apr; 156(16):623-5. PubMed ID: 25864137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The choice of antihypertensive therapy in patients with the metabolic syndrome--time to change recommendations?
    Hilgers KF; Mann JF
    Nephrol Dial Transplant; 2008 Nov; 23(11):3389-91. PubMed ID: 18687734
    [No Abstract]   [Full Text] [Related]  

  • 7. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
    Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Principles of antihypertensive therapy in metabolic syndrome].
    Sergeeva VV; Rodionova AIu; Mikhaĭlov AA; Bobyleva TA; Patsenko MB; Liferov RA
    Klin Med (Mosk); 2013; 91(6):4-8. PubMed ID: 24417059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome.
    Yilmaz MI; Sonmez A; Caglar K; Celik T; Yenicesu M; Eyileten T; Acikel C; Oguz Y; Yavuz I; Vural A
    Nephrology (Carlton); 2007 Apr; 12(2):147-53. PubMed ID: 17371337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Black HR; Davis B; Barzilay J; Nwachuku C; Baimbridge C; Marginean H; Wright JT; Basile J; Wong ND; Whelton P; Dart RA; Thadani U;
    Diabetes Care; 2008 Feb; 31(2):353-60. PubMed ID: 18000186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic approach to managing hypertension and the metabolic syndrome in primary care.
    Bestermann WH; Lackland DT; Riehle JE; Egan BM
    South Med J; 2004 Oct; 97(10):932-8. PubMed ID: 15558916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha Blockers and Metabolic Syndrome.
    Kabra NK
    J Assoc Physicians India; 2014 Sep; 62(9 Suppl):13-6. PubMed ID: 26245037
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of hypertension in patients with diabetes mellitus and metabolic syndrome in Swiss primary care.
    Schäfer HH; de Villiers JD; Sudano I; Theus GR; Sivukhina E; Burnier M; Dieterle T; Noll G
    Int J Clin Pract; 2012 Nov; 66(11):1125-6. PubMed ID: 23067037
    [No Abstract]   [Full Text] [Related]  

  • 14. Treating essential hypertension. The first choice is usually a thiazide diuretic.
    Prescrire Int; 2014 Sep; 23(152):215-20. PubMed ID: 25325125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients.
    Kintscher U; Bramlage P; Paar WD; Thoenes M; Unger T
    Cardiovasc Diabetol; 2007 Apr; 6():12. PubMed ID: 17407587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antihypertensive therapy in hypertensive patients with metabolic syndrome].
    Leoncini G; Viazzi F; Pontremoli R
    G Ital Nefrol; 2010; 27(6):588-98. PubMed ID: 21132641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypertension combination therapy with renin-angiotensin system blockers].
    Soucek M
    Vnitr Lek; 2009 Sep; 55(9):719-23. PubMed ID: 19785368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Present-day treatment of arterial hypertension].
    Schuchert A
    Med Monatsschr Pharm; 2010 Dec; 33(12):462-8: quiz 469-70. PubMed ID: 21189521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertensive treatment in patients with metabolic syndrome.
    Siegel D; Swislocki AL
    Metab Syndr Relat Disord; 2010 Apr; 8(2):95-104. PubMed ID: 20156078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACE inhibitors versus AT1 blockers in the treatment of hypertension and syndrome X.
    Feldman R
    Can J Cardiol; 2000 Aug; 16 Suppl E():41E-44E. PubMed ID: 10906626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.